Prescott Group Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$1.48M	–	167
2022 Q4	$1.48M	Buy	40,000 +4,996	+14%	+$185K	0.32%	78
2022 Q3	$985K	Buy	+35,004	New	+$985K	0.3%	79